TRIAMCINOLONE ACET 200 MG/5 ML
TRIAMCINOLONE ACETATE 200 MG/5 ML, a generic anti-inflammatory steroid, has a NADAC acquisition cost of $3.99, though hospitals typically charge significantly more than this baseline price.
About the analyst
David Park researches procedure pricing and insurance reimbursement patterns at BillRazor Research. He specializes in cost comparison across care settings and metropolitan areas. Expertise: procedure pricing, insurance reimbursement, cost comparison.
Triamcinolone acetonide is an anti-inflammatory corticosteroid used for various conditions including allergies, arthritis, and skin disorders. This generic formulation typically generates lower reimbursement rates compared to brand-name alternatives, with Medicare coverage varying based on the specific indication and administration route.
No credit card required. Results in 60 seconds.
Related pricing data
Data source: National Average Drug Acquisition Cost (NADAC) survey, published by CMS. HCPCS drug pricing codes from Medicare Part B Drug Average Sales Price file.
What NADAC means: The average price pharmacies pay to acquire this drug from wholesalers. Hospital charges for the same drug are typically higher due to facility fees, compounding, and administration costs.
Limitations: NADAC reflects pharmacy acquisition cost, not patient out-of-pocket cost. Insurance copays, formulary tiers, and manufacturer rebates affect what patients actually pay.